Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
docetaxel (taxotere) (1 trial)
vinorelbine (navelbine) (1 trial)
Breast Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (2 total)